Last reviewed · How we verify
NCT06612957
A Randomized Controlled Study of Uterine Incision Diverticulum Repair vs. no Repair During Second/Third Cesarean Section
NA trial testing Repair of uterine cicatricial diverticulum in Cesarean Scar Diverticulum in 60 participants. Not yet recruiting.
1 June 2026
Quick facts
| Lead sponsor | Shanghai First Maternal and Infant Health Hospital affiliated to Tongji University Medical School |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 20 May 2025 |
| Primary completion | 1 June 2026 |
| Estimated completion | 1 June 2027 |
Drugs / interventions tested
- Repair of uterine cicatricial diverticulum
Conditions studied
- Cesarean Scar Diverticulum — all drugs for Cesarean Scar Diverticulum →
Sponsor
Shanghai First Maternal and Infant Health Hospital affiliated to Tongji University Medical School
Who can join
18 and older, female only, with Cesarean Scar Diverticulum. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to assess the efficacy and safety of uterine incision diverticulum repair during repeat cesarean section.The main questions it aims to answer are: * Can this surgical method improve the symptom of menorrhagia？ * Is this procedure safe？ Researchers will compare experimental group(Cesarean section + diverticulum repair group) to control group(Conventional cesarean section group) to see if this surgical method works to treat or improve menorrhagia. Participants will: * randomly assigned 1:1 to the experimental group（repairing uterine diverticula during cesarean section) and the control group （Routine cesarean section without repairing the uterine incision diverticulum） * visit the hospital 42 days after surgery * followed up by telephone 6-12 months after surgery
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06612957
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06612957 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai First Maternal and Infant Health Hospital affiliated to Tongji University Medical School
- Last refreshed: 21 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06612957.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing